LexisNexis® Legal Newsroom
Second Fosamax Bellwether Case Ends In Unanimous Verdict For Defendant Merck

NEW YORK — (Mealey’s) The second federal Fosamax bellwether trial ended in a defense verdict May 6 when a jury in the U.S. District Court for the Southern District of New York unanimously found that the plaintiff did not suffer from osteonecrosis of the jaw (ONJ) as of March 31, 2004, a date...

Jury Awards Plaintiff $8 Million In Fosamax Lawsuit

NEW YORK - (Mealey's) A jury returned an $8 million compensatory damages verdict against Merck & Co. Inc. on June 25 in the U.S. District Court for the Southern District of New York in the retrial of the first Fosamax multidistrict litigation case to go to trial, according to the court's...

$8M Fosamax Verdict Remitted By MDL Judge To $1.5M Or New Damages Trial

NEW YORK -- (Mealey's) The New York federal judge overseeing the Fosamax multidistrict litigation on Oct. 4 sua sponte found that an $8 million verdict in a bellwether trial is excessive and ordered a remittitur of the verdict to $1.5 million unless plaintiff Shirley Boles wants a new trial on damages...

Merck Wins 1st State Court Fosamax Trial

ATLANTIC CITY, N.J. -- The first state court trial alleging jaw injuries from Fosamax yielded a win for the defense on Feb. 14 in the Atlantic County, N.J., Superior Court ( Alison Rosenberg v. Merck, Sharpe & Dohme Corp. , No. ATL-L-3644-08, N.J. Super., Atlantic Co.). The jury found by a...